Stock Track | Becton Dickinson Soars 5.03% Intraday After Q3 Earnings and Revenue Beat, Raises Profit Outlook

Stock Track08-06

Shares of Becton Dickinson (BDX) surged 5.03% during intraday trading on Thursday, fueled by a stronger-than-expected fiscal third-quarter earnings report. The medical technology company’s results beat Wall Street estimates on both the top and bottom lines, driven by robust demand for its drug-delivery devices and surgical equipment.

BD reported an adjusted profit of $3.23 per share for the quarter, surpassing the consensus estimate of $3.14. Revenue rose 5.4% to $4.98 billion, also exceeding analyst expectations of $4.89 billion. Segment performance was led by the Interventional unit, which saw revenue increase 6.4% to $1.41 billion, and the Connected Care segment, which grew 4.9% to $1.22 billion.

Adding to the positive momentum, the company raised the lower end of its full-year adjusted earnings per share guidance to a range of $12.62 to $12.72, up from its prior forecast of $12.52 to $12.72. Management also indicated that revenue growth is now expected to be toward the high end of its low single-digit range. Executives cited strong momentum across key growth platforms and disciplined execution as key factors behind the improved outlook.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1174298708?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-06 22:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1174298708","market":"sg","top_or_hot":-1,"title":"Stock Track | Becton Dickinson Soars 5.03% Intraday After Q3 Earnings and Revenue Beat, Raises Profit Outlook","media":"Stock Track","content":"<p>Shares of Becton Dickinson (BDX) surged 5.03% during intraday trading on Thursday, fueled by a stronger-than-expected fiscal third-quarter earnings report. The medical technology company’s results beat Wall Street estimates on both the top and bottom lines, driven by robust demand for its drug-delivery devices and surgical equipment.</p>\n<p>BD reported an adjusted profit of $3.23 per share for the quarter, surpassing the consensus estimate of $3.14. Revenue rose 5.4% to $4.98 billion, also exceeding analyst expectations of $4.89 billion. Segment performance was led by the Interventional unit, which saw revenue increase 6.4% to $1.41 billion, and the Connected Care segment, which grew 4.9% to $1.22 billion.</p>\n<p>Adding to the positive momentum, the company raised the lower end of its full-year adjusted earnings per share guidance to a range of $12.62 to $12.72, up from its prior forecast of $12.52 to $12.72. Management also indicated that revenue growth is now expected to be toward the high end of its low single-digit range. Executives cited strong momentum across key growth platforms and disciplined execution as key factors behind the improved outlook.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Becton Dickinson Soars 5.03% Intraday After Q3 Earnings and Revenue Beat, Raises Profit Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Becton Dickinson Soars 5.03% Intraday After Q3 Earnings and Revenue Beat, Raises Profit Outlook\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-08-06 22:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Becton Dickinson (BDX) surged 5.03% during intraday trading on Thursday, fueled by a stronger-than-expected fiscal third-quarter earnings report. The medical technology company’s results beat Wall Street estimates on both the top and bottom lines, driven by robust demand for its drug-delivery devices and surgical equipment.</p>\n<p>BD reported an adjusted profit of $3.23 per share for the quarter, surpassing the consensus estimate of $3.14. Revenue rose 5.4% to $4.98 billion, also exceeding analyst expectations of $4.89 billion. Segment performance was led by the Interventional unit, which saw revenue increase 6.4% to $1.41 billion, and the Connected Care segment, which grew 4.9% to $1.22 billion.</p>\n<p>Adding to the positive momentum, the company raised the lower end of its full-year adjusted earnings per share guidance to a range of $12.62 to $12.72, up from its prior forecast of $12.52 to $12.72. Management also indicated that revenue growth is now expected to be toward the high end of its low single-digit range. Executives cited strong momentum across key growth platforms and disciplined execution as key factors behind the improved outlook.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BDX","symbol_name":"碧迪医疗","start_time":0,"source_url":"","article_id":"1174298708","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1174298708","pubTimestamp":1786025212,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Becton Dickinson (BDX) surged 5.03% during intraday trading on Thursday, fueled by a stronger-than-expected fiscal third-quarter earnings report. The medical technology company’s results...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BDX":"碧迪医疗"},"translate_title":"股票跟踪 | Becton Dickinson 第三季度盈利和收入超出预期后盘中飙升 5.03%，上调利润前景","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BDX":1},"content_text":"Shares of Becton Dickinson (BDX) surged 5.03% during intraday trading on Thursday, fueled by a stronger-than-expected fiscal third-quarter earnings report. The medical technology company’s results beat Wall Street estimates on both the top and bottom lines, driven by robust demand for its drug-delivery devices and surgical equipment.\nBD reported an adjusted profit of $3.23 per share for the quarter, surpassing the consensus estimate of $3.14. Revenue rose 5.4% to $4.98 billion, also exceeding analyst expectations of $4.89 billion. Segment performance was led by the Interventional unit, which saw revenue increase 6.4% to $1.41 billion, and the Connected Care segment, which grew 4.9% to $1.22 billion.\nAdding to the positive momentum, the company raised the lower end of its full-year adjusted earnings per share guidance to a range of $12.62 to $12.72, up from its prior forecast of $12.52 to $12.72. Management also indicated that revenue growth is now expected to be toward the high end of its low single-digit range. Executives cited strong momentum across key growth platforms and disciplined execution as key factors behind the improved outlook.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1174298708","isCrawlerRequest":true}